Virchow Lab FY 2019
Virchow Lab FY 2019
Virchow Lab FY 2019
Details of principal business activities contributing 10% or more of total turnover of company [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Product/service 1 Product/service 2
Principal business activities of company [Axis]
[Member] [Member]
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of principal business activities contributing 10% or more of total turnover
of company [Abstract]
Details of principal business activities contributing 10% or more of total
turnover of company [LineItems]
Name of main product/service SULPHAMETHOXAZOLE Oxalic Acid
Description of main product/service SULPHAMETHOXAZOLE Oxalic Acid
NIC code of product/service 3003 3003
Percentage to total turnover of company 74.00% 12.00%
2
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
N o t
Disclosure of statement on declaration given by independent directors Applicable
under section 149(6) [TextBlock]
3
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details of directors or key managerial personnels who were Textual information (18)
appointed or have resigned during year [TextBlock] [See below]
Disclosure of companies which have become or ceased to be its
Textual information (19)
subsidiaries, joint ventures or associate companies during [See below]
year [TextBlock]
Details relating to deposits covered under chapter v of companies act Textual information (20)
[TextBlock] [See below]
Details of deposits which are not in compliance with requirements Textual information (21)
of chapter v of act [TextBlock] [See below]
Details of significant and material orders passed by
Textual information (22)
regulators or courts or tribunals impacting going concern [See below]
status and company’s operations in future [TextBlock]
Details regarding adequacy of internal financial controls with Textual information (23)
reference to financial statements [TextBlock] [See below]
Disclosure of contents of corporate social responsibility policy Textual information (24)
[TextBlock] [See below]
Disclosure of reasons if company fails to spend prescribed amount on CSR Others
We spend the money on need
base. However, we will
spend the balance unspent
Disclosure of other reasons if company fails to spend prescribed amount amount in future as per our
on CSR company CSR policy by
considering the present
provisions as per
Companies Act.
Disclosure of appointment and remuneration of director or Textual information (25)
managerial personnel if any, in the financial year [TextBlock] [See below]
Details of remuneration of director or managerial personnel [Abstract]
Number of meetings of board [pure] 0
Details of signatories of board report [Abstract]
Name of director signing board report [Abstract]
4
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
To
The Members of
Your Directors have pleasure in presenting the 37th Directors’ Report on the business and operations of the Company together with the audited
Financial Statements for the year ended 31st March, 2019.
The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under
Standalone
2018-19 2017-18
5
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
PERFORMANCE REVIEW:
Standalone:
The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.
TRANSFER TO RESERVES:
6
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
During the period, the Company has transferred Rs. 17.87 lakhs to capital redemption reserve.
DIVIDEND:
During the year, the Directors do not recommend payment of any dividend.
During the period under review and the date of Board’s Report there was no change in the nature of Business.
MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT:
There are no material changes and commitments affecting financial position of the company between 31st March, 2019 and the date of Boards’
Report. (i.e. 21.08.2019)
The Board of Directors met 4 times during the year on 02.06.2018, 18.07.2018, 06.09.2018 and 29.12.2018 the maximum gap between any two
meetings was less than four months, as stipulated under the provisions of Companies Act, 2013.
PUBLIC DEPOSITS:
The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.
7
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
During the period under review, the Company’s Authorized Share capital of the company stand at Rs. 1,50,00,000 divided into 1,50,000 equity
shares of Rs.100/- each.
The company bought back 17,867 equity shares at a price of Rs. 24,900/- each aggregating to Rs.44.49 crores and accordingly the Paid up capital
of the Company stands reduced to Rs. 71,47,000 divided into 71,470 equity shares of Rs. 100/- each.
As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.
NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:
During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.
INSURANCE:
The company's properties have been adequately insured against major risks. All the insurable interests of your Company including inventories,
buildings, plant and machinery, stock and receivables under legislative enactments are adequately insured.
A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY
8
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:
Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.
· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.
· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.
· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.
Pursuant to the provisions of Sec. 134(5) of the Companies Act, 2013 the Board of Directors of your Company hereby certifies and confirms that:
a. In the preparation of the Annual Accounts, the applicable accounting standards have been followed along with proper explanation relating to
material departures;
9
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
b. The Directors have selected such accounting policies and applied them consistently and made judgment and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the
Company for that period;
c. The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Companies Act, 2013 for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. The Directors have prepared the Annual accounts on a going concern basis.
e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively and
f. The Directors had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate
and were operating effectively.
The Ministry of Corporate Affairs vide its notification dated 16th February, 2015 has notified the Companies (Indian Accounting Standards)
Rules, 2015. In pursuance of the said notification, the Company has adopted Indian Accounting Standards (IndAS) with effect from 01st April,
2017.
DETAILS IN REPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OTHER THAN THOSE
WHICH ARE REPORTABLE TO CENTRAL GOVERNMENT.
There were no frauds reported by the auditors as per section 143 (12) other than those which are reportable to Central Government.
10
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
STATUTORY AUDITORS:
M/s Ramana Reddy & Associates, Chartered Accountants, Hyderabad was appointed as Statutory Auditors in the AGM held on 30.09.2014 upto
31.03.2019. Therefore their re-appointment as statutory auditors for a period of five (5) years commencing from 01.04.2019 to 31.03.2024. .
COST AUDITOR:
Sri P. Srinivas, Cost Accountant, Hyderabad (Registration No. 100309), acting as cost auditor to audit the cost records maintained by the
company for the financial year 2019-2020, on a remuneration of Rs. 1,00,000./-
SECRETARIAL AUDITOR:
Pursuant to the provisions of Section 134(3) (f) & Section 204 of the Companies Act, 2013, Secretarial audit report as provided by M/s. S. S.
Reddy & Associates, Practicing Company Secretaries is annexed to this Report as an ANNEXURE 2.
The Board has duly reviewed the Statutory Auditor’s Report and Secretarial Audit Report for the year ended March 31, 2019 and has noted that
the same does not have any reservation, qualification or adverse remarks.
As required pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules,
2014, an extract of annual return in MGT 9 as a part of this Annual Report as ANNEXURE 3.
11
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The required information as per Section 134(3)(m) of the Companies Act, 2013 is provided in ANNEXURE 4.
The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.
During the period under review, there is no material or serious observations have been noticed for inefficiency or inadequacy of such controls.
During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.
IN CASE OF A COMPANY COVERED UNDER SUB-SECTION (1) OF SECTION 178, COMPANY’S POLICY ON DIRECTORS”
APPOINTMENT AND REMUNERATION INCULDING CRITERIA FOR DETERMING QUALIFICATIONS, POSITIVE ATTRIBUTES,
INDEPENDENCE OF A DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178:
The Nomination & Remuneration Committee constituted and the Policy framed and adopted by the Company is in line with the provisions of with
Section 178 of the Companies Act, 2013 and the details of the composition of the Committee are given below:
12
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Policy adopted by the Company is placed on website of the company i.e., www.virchows.com.
The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.
AUDIT COMMITTEE:
The Audit Committee of the Company is constituted in line with the provisions of with Section 177 of the Companies Act, 2013 and the details of
the composition of the Committee are given below:
COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:
In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.
13
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:
The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5
All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.
Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.
STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF REMUNERATION DRAWN AND THE NAME
OF EVERY EMPLOYEE:
A statement showing the names of the top ten employees in terms of remuneration drawn and the name of every employee is not applicable.
SECRETARIAL STANDARDS:
14
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:
The Company always endeavors to create and provide an environment that is free from discrimination and harassment including sexual
harassment. Directors further states that during the year under review, there were no cases filed pursuant to the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act, 2013.
ACKNOWLEDGEMENTS:
The directors would like to express their grateful appreciation for assistance and co-operation received from clients, banks, investors,
Government, other statutory authorities and all others associated with the company. Your directors also wish to place on record their deep sense
of appreciation for the excellent contribution made by the employees at all levels, which enabled the company to achieve sustained growth in the
operational performance during the year under review.
15
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Date: 31.08.2019
Place: Hyderabad
16
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details of material changes and commitment occurred during period affecting financial position of company
MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT: There are no material changes and commitments affecting financial position of the company
between 31st March, 2019 and the date of Boards’ Report. (i.e. 21.08.2019)
The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.
17
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
RELATED PARTY TRANSACTIONS:
All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.
Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.
18
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of extract of annual return as provided under section 92(3) [Text Block]
FORM NO. MGT.9
[Pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules, 2014]
i) CIN U24232TG1982PLC003368
All the business activities contributing 10 % or more of the total turnover of the company shall be stated:-
Name and
NIC Code of % to total
Description of
19
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
1 Sulphamethoxazole 74.12
IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)
20
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
%
No. of Shares held at No. of Shares held Change
Category of Shareholders the beginning of the at the end of the during
year year the
year
% of % of
Demat Physical Total Total Demat Physical Total Total
Shares Shares
A. Promoters
Indian
Individual/ HUF
-- 89337 89337 100 -- 71470 71470 100 --
Central Govt
-- -- -- -- -- -- -- -- --
Bodies Corp.
-- -- -- -- -- -- -- -- --
Banks/FI
-- -- -- -- -- -- -- -- --
Any Other..
-- -- -- -- -- -- -- -- --
(2) Foreign
a) NRIs – Individuals -- -- -- -- -- -- -- -- --
21
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
b) Other – Individuals
-- -- -- -- -- -- -- -- --
c) Bodies Corp.
-- -- -- -- -- -- -- -- --
d) Banks / FI
-- -- -- -- -- -- -- -- --
e) Any Other....
-- -- -- -- -- -- -- -- --
(A)(1)+(A)( 2)
B. Public Shareholding
1. Institutions
-- -- -- -- -- -- -- -- --
a) Mutual Funds
-- -- -- -- -- -- -- -- --
b) Banks/FI
-- -- -- -- -- -- -- -- --
c) Central Govt
-- -- -- -- -- -- -- -- --
d) State Govt(s)
-- -- -- -- -- -- -- -- --
22
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
f) Insurance Companies
-- -- -- -- -- -- -- -- --
g) FIIs
-- -- -- -- -- -- -- -- --
i) Others (specify)
-- -- -- -- -- -- -- -- --
Sub-total (B)(1):-
-- -- -- -- -- -- -- -- --
2. Non-Institutions
a) Bodies Corp.
-- -- -- -- -- -- -- -- --
i) Indian
-- -- -- -- -- -- -- -- --
ii) Overseas
-- -- -- -- -- -- -- -- --
b) Individuals
-- -- -- -- -- -- -- -- --
23
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
c) Others (specify)
-- -- -- -- -- -- -- -- --
Sub-total (B)(2):-
-- -- -- -- -- -- -- -- --
Shareholding at Shareholding
SlN
Shareholder's Name the beginning of at the end of
o.
the year the year
%of Shares
% of total Pledged/ % of total %of Shares Pledged/ % change in share
No. of Shares Shares of the encumbered No. of Shares Shares of the encumbered to total holding during
company to total company shares the year
shares
Dr. N. Venkata
1 3779 4.23 -- 3024 4.23 --
Reddy
Sri. D. Ravindra
Reddy
4 6379 7.14 -- 5103 7.14 -- --
Dr. L. V. Subba
Reddy
24
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Dr. Nandigala
6 7419 8.30 -- 5935 8.30 -- --
Hemanth
Sri. Nandigala
7 7419 8.30 -- 5935 8.30 -- --
Prashanth
Sri. M. Maha
8 8322 9.32 -- 6658 9.32 -- --
Vishnu
Smt. M. Lakshmi
Prasanna
12 1907 2.13 -- 1524 2.13 -- --
Smt. L. Naga
Amma
13 0 0 -- 0 0 -- 0
Smt. N.
Anasuyamma
14 895 1.00 -- 716 1.00 -- --
Sri. N. Vijaya
17 1786 2.00 -- 1429 2.00 -- --
Bhaskar Reddy
Sri. G.
18 Chandramouleswara 1430 1.60 -- 1144 1.60 -- --
Reddy
Sri. C. Sudhakar
20 76 0.09 -- 61 0.09 -- --
Reddy
Dr. L. Sunita
25
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Sri. N. Pareswara
0.04
Reddy
25 38 -- 30 0.04 -- --
89337
Total 100 -- 71470 100 -- --
Cumulative
Sl. Shareholding at the beginning
Shareholding
No. of the year
during the year
% of total % of total
No. of shares shares of the No. of shares shares of the
company company
26
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
(iv) Shareholding Pattern of top ten Shareholders (other than Directors, Promoters and Holders of GDRs and ADRs):
Cumulative
Sl. Shareholding at the
Shareholding during
No. beginning of the year
the year
% of total shares of
Date of
the No. of % of total shares
No. of shares increase/ Reason
shares of the company
decrease
company
27
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
1 Reddy 3779 4.23 17867 equity shares at Rs. 25,000 per 3024 4.23
share.
M. Narayana
2 6017 6.74 4714 6.74
Reddy
Sri M. Maha
3 8322 9.32 6658 9.32
Vishnu
Dr. L. V. Subba
4 6922 7.74 5538 7.75
Reddy
Dr. Nandigala
5 7419 8.30 5935 8.30
Hemanth-
Sri. Nandigala
6 719 8.30 5935 8.30
Prasanth
10 S. Swetha - - - - - -
K. V. Ravindra
11 - - - -
Reddy
A. Venkata
12 - - - -
Reddy
28
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
V. INDEBTEDNESS:
Indebtedness of the Company including interest outstanding/accrued but not due for payment:
(Rs. In lakhs)
Secured Loans
Total
excluding Unsecured Loans Deposits
Indebtedness
deposits
i) Principal Amount
1761.99
ii) Interest due but not paid - - 1761.99
-
iii) Interest accrued but not due - - -
-
- - -
1761.99 1761.99
Total (i+ii+iii) - -
• Addition
425.05 - - 425.05
• Reduction
- - - -
29
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
M. Narayana Reddy- MD
N. Venkata Reddy-
MD
Gross salary
2. Stock Option -- -- --
3. Sweat Equity -- -- --
Commission
- others, specify...
Companies Act,
Ceiling as per the Act Companies Act, 2013 Companies Act, 2013
2013
30
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
3. Independent Directors -- -- --
• Commission
Total (1) -- -- --
• Commission -- -- --
Total (2) -- -- --
Total (B) = (1 + 2)
Overall Ceiling as per the Act Companies Act, 2013 Companies Act, 2013 Companies Act, 2013
Company
CEO CFO Total
Secretary
Gross salary
(a) Salary as per provisions contained in section 17(1) of the Income-tax Act,
1961
1. -- -- -- --
(b) Value of perquisites u/s 17(2) Income-tax Act, 1961
(c) Profits in lieu of salary under section 17(3) Income-tax Act, 1961
2. Stock Option -- -- -- --
31
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
3. Sweat Equity -- -- -- --
Commission
4. - as % of profit -- -- -- --
- others, specify...
Total -- -- -- --
Details of Penalty/
Section of the Brief Punishment/ Authority Appeal made, if any (give
Type
Companies Act Description Compounding fees [RD/NCLT/COURT] Details)
imposed
A. COMPANY
Penalty -- -- -- --
Punishment -- -- -- --
Compounding -- -- -- --
B. DIRECTORS
Penalty -- -- -- --
Punishment -- -- -- --
Compounding -- -- -- --
C. OTHER OFFICERS IN
DEFAULT
Penalty -- -- -- --
Punishment -- -- -- --
32
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Compounding -- -- -- --
Date: 31.08.2019
Place: Hyderabad
33
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure for companies covered under section 178(1) on directors appointment and remuneration including other
matters provided under section 178(3) [Text Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:
· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.
· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.
· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.
Disclosure of statement on development and implementation of risk management policy [Text Block]
A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY
INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:
Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.
34
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details on policy development and implementation by company on corporate social responsibility initiatives taken
during year [Text Block]
COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:
In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.
The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:
The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5
Report on highlights on performance of subsidiaries, associates and joint venture companies and their contribution to
overall performance of the companies during the period under report [Text Block]
INFORMATION ABOUT THE FINANCIAL PERFORMANCE OF SUBSIDIARIES / ASSOCIATES/ JOINT VENTURES:
As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.
35
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure as per rule 8(5) of companies accounts rules 2014 [Text Block]
DIRECTORS’ REPORT
To
The Members of
Your Directors have pleasure in presenting the 37th Directors’ Report on the business and operations of the Company together with the audited
Financial Statements for the year ended 31st March, 2019.
The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under
Standalone
2018-19 2017-18
36
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
PERFORMANCE REVIEW:
Standalone:
The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.
TRANSFER TO RESERVES:
37
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
During the period, the Company has transferred Rs. 17.87 lakhs to capital redemption reserve.
DIVIDEND:
During the year, the Directors do not recommend payment of any dividend.
During the period under review and the date of Board’s Report there was no change in the nature of Business.
MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT:
There are no material changes and commitments affecting financial position of the company between 31st March, 2019 and the date of Boards’
Report. (i.e. 21.08.2019)
The Board of Directors met 4 times during the year on 02.06.2018, 18.07.2018, 06.09.2018 and 29.12.2018 the maximum gap between any two
meetings was less than four months, as stipulated under the provisions of Companies Act, 2013.
PUBLIC DEPOSITS:
The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.
38
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
During the period under review, the Company’s Authorized Share capital of the company stand at Rs. 1,50,00,000 divided into 1,50,000 equity
shares of Rs.100/- each.
The company bought back 17,867 equity shares at a price of Rs. 24,900/- each aggregating to Rs.44.49 crores and accordingly the Paid up capital
of the Company stands reduced to Rs. 71,47,000 divided into 71,470 equity shares of Rs. 100/- each.
As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.
NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:
During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.
INSURANCE:
The company's properties have been adequately insured against major risks. All the insurable interests of your Company including inventories,
buildings, plant and machinery, stock and receivables under legislative enactments are adequately insured.
A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY
39
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:
Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.
· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.
· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.
· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.
Pursuant to the provisions of Sec. 134(5) of the Companies Act, 2013 the Board of Directors of your Company hereby certifies and confirms that:
a. In the preparation of the Annual Accounts, the applicable accounting standards have been followed along with proper explanation relating to
material departures;
40
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
b. The Directors have selected such accounting policies and applied them consistently and made judgment and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the
Company for that period;
c. The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Companies Act, 2013 for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;
d. The Directors have prepared the Annual accounts on a going concern basis.
e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively and
f. The Directors had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate
and were operating effectively.
The Ministry of Corporate Affairs vide its notification dated 16th February, 2015 has notified the Companies (Indian Accounting Standards)
Rules, 2015. In pursuance of the said notification, the Company has adopted Indian Accounting Standards (IndAS) with effect from 01st April,
2017.
DETAILS IN REPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OTHER THAN THOSE
WHICH ARE REPORTABLE TO CENTRAL GOVERNMENT.
There were no frauds reported by the auditors as per section 143 (12) other than those which are reportable to Central Government.
41
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
STATUTORY AUDITORS:
M/s Ramana Reddy & Associates, Chartered Accountants, Hyderabad was appointed as Statutory Auditors in the AGM held on 30.09.2014 upto
31.03.2019. Therefore their re-appointment as statutory auditors for a period of five (5) years commencing from 01.04.2019 to 31.03.2024. .
COST AUDITOR:
Sri P. Srinivas, Cost Accountant, Hyderabad (Registration No. 100309), acting as cost auditor to audit the cost records maintained by the
company for the financial year 2019-2020, on a remuneration of Rs. 1,00,000./-
SECRETARIAL AUDITOR:
Pursuant to the provisions of Section 134(3) (f) & Section 204 of the Companies Act, 2013, Secretarial audit report as provided by M/s. S. S.
Reddy & Associates, Practicing Company Secretaries is annexed to this Report as an ANNEXURE 2.
The Board has duly reviewed the Statutory Auditor’s Report and Secretarial Audit Report for the year ended March 31, 2019 and has noted that
the same does not have any reservation, qualification or adverse remarks.
As required pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules,
2014, an extract of annual return in MGT 9 as a part of this Annual Report as ANNEXURE 3.
42
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The required information as per Section 134(3)(m) of the Companies Act, 2013 is provided in ANNEXURE 4.
The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.
During the period under review, there is no material or serious observations have been noticed for inefficiency or inadequacy of such controls.
During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.
IN CASE OF A COMPANY COVERED UNDER SUB-SECTION (1) OF SECTION 178, COMPANY’S POLICY ON DIRECTORS”
APPOINTMENT AND REMUNERATION INCULDING CRITERIA FOR DETERMING QUALIFICATIONS, POSITIVE ATTRIBUTES,
INDEPENDENCE OF A DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178:
The Nomination & Remuneration Committee constituted and the Policy framed and adopted by the Company is in line with the provisions of with
Section 178 of the Companies Act, 2013 and the details of the composition of the Committee are given below:
43
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Policy adopted by the Company is placed on website of the company i.e., www.virchows.com.
The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.
AUDIT COMMITTEE:
The Audit Committee of the Company is constituted in line with the provisions of with Section 177 of the Companies Act, 2013 and the details of
the composition of the Committee are given below:
COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:
In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.
44
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:
The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5
All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.
Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.
STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF REMUNERATION DRAWN AND THE NAME
OF EVERY EMPLOYEE:
A statement showing the names of the top ten employees in terms of remuneration drawn and the name of every employee is not applicable.
SECRETARIAL STANDARDS:
45
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:
The Company always endeavors to create and provide an environment that is free from discrimination and harassment including sexual
harassment. Directors further states that during the year under review, there were no cases filed pursuant to the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act, 2013.
ACKNOWLEDGEMENTS:
The directors would like to express their grateful appreciation for assistance and co-operation received from clients, banks, investors,
Government, other statutory authorities and all others associated with the company. Your directors also wish to place on record their deep sense
of appreciation for the excellent contribution made by the employees at all levels, which enabled the company to achieve sustained growth in the
operational performance during the year under review.
46
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Date: 31.08.2019
Place: Hyderabad
47
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under
Standalone
2018-19 2017-18
PERFORMANCE REVIEW:
48
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Standalone:
The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.
Details of directors or key managerial personnels who were appointed or have resigned during year [Text Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:
· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.
· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.
· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.
49
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of companies which have become or ceased to be its subsidiaries, joint ventures or associate companies
during year [Text Block]
NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:
During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.
Details relating to deposits covered under chapter v of companies act [Text Block]
PUBLIC DEPOSITS:
The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.
Details of deposits which are not in compliance with requirements of chapter v of act [Text Block]
PUBLIC DEPOSITS:
The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.
Details of significant and material orders passed by regulators or courts or tribunals impacting going concern status
and company’s operations in future [Text Block]
SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS:
During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.
50
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Details regarding adequacy of internal financial controls with reference to financial statements [Text Block]
DISCLOSURE OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS
The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.
51
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
[Pursuant to section 135 of the Companies Act, 2013 and Rule 9 of the Companies (Corporate Social Responsibility) Rules, 2014]
1. A brief Outline of Company’s CSR Policy, including overview of projects or programmes undertaken/ proposed to be undertaken:
The CSR committee of the Board has developed CSR Policy consist of
a) Eradicating poverty, promoting health care & sanitation and making available safe drinking water
b) Promoting education
d) Sports promotion
3. Average net profits of the company for last three financial years
The average net profit of the Company for the last three financial years was Rs. 59,58,09,750
52
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company has allocated 2% of the average net profits of the last three financial years for the CSR initiative which amounts to Rs. 1,19,16,195
2016-17 34,81,066
2017-18 – 1,33,42,522
2018-19 - 1,19,16,195
2,87,39,783
(c) Manner in which the amount spent during the financial year is detailed below:
Promotion of
1 32.92
education
Promotion of
2 7.20
sports
Promotion of
3 28.42
health care
Providing safe
4 4.87
drinking water
Rural
5 18.33
development
TOTAL 91.74
53
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
6. In case the company has failed to spend the 2% of the average net profits of the last three financial years or any part thereof, the company shall
provide the reasons for not spending the amount in its board report:
We spend the money on need base. However, we will spend the balance unspent amount in future as per our company CSR policy by considering
the present provisions as per Companies Act.
Disclosure of appointment and remuneration of director or managerial personnel if any, in the financial year [Text
Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:
· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.
· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.
· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.
54
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
55
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Auditor's Clause not
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] favourable remark applicable
[Member] [Member]
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in
auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in
auditors' report [LineItems]
Textual information
Disclosure in auditors report relating to fixed assets (26) [See below]
(i) (a) The company
has maintained
proper records
showing full
Disclosure relating to quantitative details of fixed assets particulars including
quantitative details
and situation of fixed
assets.
Disclosure relating to physical verification and material discrepancies of fixed Textual information
assets (27) [See below]
Textual information
Disclosure relating to title deeds of immovable properties (28) [See below]
(ii) Physical
verification of
inventory has been
conducted at
Disclosure in auditors report relating to inventories reasonable intervals
by the management
and no material
discrepancies were
noticed.
Textual information
Disclosure in auditors report relating to loans (29) [See below]
Disclosure about loans granted to parties covered under section 189 of companies Textual information
act (30) [See below]
Textual information
Disclosure relating to terms and conditions of loans granted (31) [See below]
Textual information
Disclosure regarding receipt of loans granted (32) [See below]
Textual information
Disclosure regarding terms of recovery of loans granted (33) [See below]
Disclosure in auditors report relating to compliance with Section 185 and 186 of Textual information
Companies Act, 2013 (34) [See below]
Textual information
Disclosure in auditors report relating to deposits accepted (35) [See below]
Textual information
Disclosure in auditors report relating to maintenance of cost records (36) [See below]
Textual information
Disclosure in auditors report relating to statutory dues [TextBlock] (37) [See below]
Disclosure relating to regularity in payment of undisputed statutory dues Textual information
[TextBlock] (38) [See below]
(b) According to the
information and
explanations given
to us, there are no
dues of income tax,
Disclosure relating to disputed statutory dues [TextBlock] customs duty, goods
and service tax and
cess which have not
been deposited on
account of any
dispute.
56
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
57
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure about loans granted to parties covered under section 189 of companies act
(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.
58
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013
(iv) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the Company
has not provided any loans, investments, guarantees, and security during the year as referred to in sections 185 and 186 of the Companies Act,
2013.
Disclosure in auditors report relating to public offer and term loans used for purpose for which those were raised
(ix) The company did not raise any money by way of initial public offer or further public offer (including debt instruments) and term loans during
the year. Accordingly, paragraph 3 (ix) of the Order is not applicable.
59
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure in auditors report relating to fraud by the company or on the company by its officers or its employees
reported during period
(x) To the best of our knowledge and according to the information and explanations given to us, no material fraud by the company or on the
company by its officers or employees has been noticed or reported during the course of our audit.
Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible
debentures
(xiv) According to the information and explanations given to us and based on our examination of the records of the company, the company has
not made any preferential allotment or private placement of shares or fully or partly convertible debentures during the year.
Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him
(xv) According to the information and explanations given to us and based on our examination of the records of the company, the company has not
entered into any non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3 (xv) is not applicable.
60
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Email:rr.associates83@gmail.com
To
The Members of
Opinion
We have audited the accompanying Ind AS financial statements of VIRCHOW LABORATORIES LIMITED (“the Company”), which comprise
the Balance Sheet as at 31st March, 2019, the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash
Flows and the Statement of Changes in Equity for the year then ended, and a summary of the significant accounting policies and other
explanatory information.
In our opinion and to the best of our information and according to the explanations given to us, the aforesaid Ind AS financial statements give the
61
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with the
Indian Accounting Standards prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as
amended, (“Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2019, the
profit and total comprehensive income, changes in equity and its cash flows for the year ended on that date
We conducted our audit of the Ind AS financial statements in accordance with the Standards on Auditing (SAs) specified under section 143(10) of
the Companies Act, 2013. Our responsibilities under those Standards are further described in the Auditor’s Responsibilities for the Audit of the
Ind AS Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the
Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the Ind AS financial statements
under the provisions of the Companies Act, 2013 and the Rules there under, and we have fulfilled our other ethical responsibilities in accordance
with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a
basis for our audit opinion on the separate Ind AS financial statements.
The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013 (“the Act”) with respect to
the preparation of these Standalone Ind AS financial statements that give a true and fair view of the state of affairs (financial position), profit or
loss (financial performance including other comprehensive income), cash flows and changes in equity of the Company in accordance with the
accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance
with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities;
selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design,
implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and
completeness of the accounting records, relevant to the preparation and presentation of the Standalone Ind AS financial statements that give a true
and fair view and are free from material misstatement, whether due to fraud or error.
In preparing the Standalone Ind AS financial statements, management is responsible for assessing the Company’s ability to continue as a going
concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either
intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
The Board of Directors are also responsible for overseeing the company’s financial reporting process.
Auditor’s Responsibilities for the Audit of the Standalone Ind AS Financial Statements
Our objectives are to obtain reasonable assurance about whether the Standalone Ind AS financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of
62
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to
influence the economic decisions of users taken on the basis of these standalone Ind AS financial statements.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We
also:
· Identify and assess the risks of material misstatement of the standalone Ind AS financial statements, whether due to fraud or error, design
and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our
opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
· Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances. Under section 143(3)(i) of the Companies Act, 2013, we are also responsible for expressing our opinion on whether the company
has adequate internal financial controls system in place and the operating effectiveness of such controls.
· Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by
management.
· Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained,
whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a
going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures
in the Ind AS financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence
obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going
concern.
· Evaluate the overall presentation, structure and content of the standalone Ind AS financial statements, including the disclosures, and
whether the standalone Ind AS financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant
audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and
where applicable, related safeguards.
63
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of
the standalone Ind AS financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor’s
report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter
should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public
interest benefits of such communication.
1. As required by the Companies (Auditor’s Report) Order, 2016 (“the Order”) issued by the Central Government in terms of Section 143(11)
of the Act, we give in “Annexure A” a statement on the matters specified in paragraphs 3 and 4 of the Order.
a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit.
b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of
those books.
c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, Statement of Changes in Equity and the
Statement of Cash Flow dealt with by this Report are in agreement with the relevant books of account.
d) In our opinion, the aforesaid standalone Ind AS financial statements comply with the Indian Accounting Standards prescribed under
section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.
e) On the basis of the written representations received from the directors as on 31st March, 2019 taken on record by the Board of Directors,
none of the directors is disqualified as on 31st March, 2019 from being appointed as a director in terms of Section 164(2) of the Act.
f) With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating effectiveness of
such controls, refer to our Report in “Annexure B”.
64
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
g) With respect to the other matters to be included in the Auditor’s Report in accordance with the requirements of section 197(16) of the Act,
as amended:
In our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its
directors during the year is in accordance with the provisions of section 197 of the Act.
h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors)
Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:
i. The Company does not have any pending litigations which would impact its financial position.
ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.
iii. There were no amounts required to be transferred, to the Investor Education and Protection Fund by the Company.
CHARTERED ACCOUNTANTS
65
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
PARTNER
Membership No.227799
PLACE: HYDERABAD
DATE: 31.08.2019
(i) (a) The company has maintained proper records showing full particulars including quantitative details and situation of fixed assets.
(b) The fixed assets of the company have been physically verified by the management during the year as per a programme of verification,
which in our opinion is reasonable having regard to the size of the company and the nature of its fixed assets. No material discrepancies were
noticed on such verification.
(c) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the title
deeds of immovable properties are held in the name of the company.
(ii) Physical verification of inventory has been conducted at reasonable intervals by the management and no material discrepancies were
noticed.
(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained
under section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.
66
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
(iv) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the
Company has not provided any loans, investments, guarantees, and security during the year as referred to in sections 185 and 186 of the
Companies Act, 2013.
(v) In our opinion and according to the information and explanations given to us, the company has not accepted any deposits in terms of
directives issued by Reserve Bank of India and the provisions of sections 73 to 76 or any other relevant provisions of the Companies Act and the
rules framed there under are not applicable.
(vi) In our opinion and according to the information and explanations given to us, the company has maintained the cost records as
prescribed by the Central Government in accordance with the provisions of Section 148(1) of the Act. However, we have not made detailed
examination of the same.
(vii) (a) The company is generally regular in depositing with appropriate authorities undisputed statutory dues including provident fund,
employees’ state insurance, income tax, goods and service tax, custom duty, cess and other material statutory dues as applicable to it.
According to the information and explanations given to us, no undisputed amounts payable in respect of income tax, goods and service tax,
customs duty, and cess were in arrears, wherever applicable, as at 31st March, 2019 for a period of more than six months from the date they
became payable.
(b) According to the information and explanations given to us, there are no dues of income tax, customs duty, goods and service tax and cess
which have not been deposited on account of any dispute.
(viii) The company has not availed any loans or borrowings from a financial institution or banks. Accordingly, paragraph 3(viii) of the
Order is no applicable.
(ix) The company did not raise any money by way of initial public offer or further public offer (including debt instruments) and term
loans during the year. Accordingly, paragraph 3 (ix) of the Order is not applicable.
(x) To the best of our knowledge and according to the information and explanations given to us, no material fraud by the company or on
the company by its officers or employees has been noticed or reported during the course of our audit.
67
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
(xi) According to the information and explanations given to us and basis on our examination of the records of the company, the company
has paid/provided for managerial remuneration in accordance with requisite approvals mandated by the provisions of section 197 read with
schedule V to the act.
(xii) In our opinion and according to the information and explanations given to us, the company is not a nidhi company. Accordingly,
paragraph 3 (xii) is not applicable.
(xiii) According to the information and explanations given to us and based on our examination of the records of the company, transactions
with related parties are in compliance with section 188 of the Companies Act and details of such transactions have been disclosed in the
standalone Ind AS financial statements as required by the applicable accounting standards.
(xiv) According to the information and explanations given to us and based on our examination of the records of the company, the company
has not made any preferential allotment or private placement of shares or fully or partly convertible debentures during the year.
(xv) According to the information and explanations given to us and based on our examination of the records of the company, the company
has not entered into any non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3 (xv) is not applicable.
(xvi) The company is not required to be registered under section 45-IA of the Reserve Bank of India Act, 1934.
CHARTERED ACCOUNTANTS
PLACE: HYDERABAD
DATE: 31.08.2019
(CA.RAJASEKHAR REDDY A)
PARTNER
Membership No.227799
68
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Report on the Internal Financial Controls under Clause (i) of Sub-section 3 of Section 143 of the
We have audited the internal financial controls over financial reporting of VIRCHOW LABORATORIES LIMITED (“the Company”) as of 31
March 2019 in conjunction with our audit of the standalone Ind AS financial statements of the Company for the year ended on that date.
The Company’s management is responsible for establishing and maintaining internal financial controls based on the internal control over financial
reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of
Internal Financial Controls over Financial Reporting issued by the Institute of Chartered Accountants of India (‘ICAI’). These responsibilities
include the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the
orderly and efficient conduct of its business, including adherence to company’s policies, the safeguarding of its assets, the prevention and
detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial
information, as required under the Companies Act, 2013.
Auditors’ Responsibility
Our responsibility is to express an opinion on the Company's internal financial controls over financial reporting based on our audit. We conducted
our audit in accordance with the Guidance Note on Audit of Internal Financial Controls over Financial Reporting (the “Guidance Note”) and the
Standards on Auditing, issued by ICAI and deemed to be prescribed under section 143(10) of the Companies Act, 2013, to the extent applicable to
an audit of internal financial controls, both applicable to an audit of Internal Financial Controls and, both issued by the Institute of Chartered
Accountants of India. Those Standards and the Guidance Note require that we comply with ethical requirements and plan and perform the audit to
obtain reasonable assurance about whether adequate internal financial controls over financial reporting was established and maintained and if
such controls operated effectively in all material respects.
69
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial controls system over financial
reporting and their operating effectiveness. Our audit of internal financial controls over financial reporting included obtaining an understanding of
internal financial controls over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. The procedures selected depend on the auditor’s judgment, including the
assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the Company’s
internal financial controls system over financial reporting.
A company's internal financial control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
A company's internal financial control over financial reporting includes those policies and procedures that(1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorisations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorised
acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of collusion or improper
management override of controls, material misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation
of the internal financial controls over financial reporting to future periods are subject to the risk that the internal financial control over financial
reporting may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate.
Opinion
70
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
In our opinion, the Company has, in all material respects, an adequate internal financial controls system over financial reporting and such internal
financial controls over financial reporting were operating effectively as at 31 March 2019, based on the internal control over financial reporting
criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of Internal
Financial Controls Over Financial Reporting issued by the Institute of Chartered Accountants of India.
CHARTERED ACCOUNTANTS
PLACE: HYDERABAD
DATE: 31.08.2019
PARTNER
Membership No.227799
71
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
72
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
73
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Basic earnings (loss) per share from discontinued operations [INR/shares] 0 [INR/shares] 0
[INR/shares]
Total basic earnings (loss) per share 4,175.19
[INR/shares] 2,465.96
Diluted earnings (loss) per share from discontinued operations [INR/shares] 0 [INR/shares] 0
[INR/shares]
Total diluted earnings (loss) per share 4,175.19
[INR/shares] 2,465.96
74
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
75
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
76
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
77
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
78
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Net cash flows from (used in) financing activities -5,060.25 -7,768.13
Net increase (decrease) in cash and cash equivalents before effect of
1,420.28 -1,244.72
exchange rate changes
Net increase (decrease) in cash and cash equivalents 1,420.28 -1,244.72
Cash and cash equivalents cash flow statement at end of period 1,446.94 26.66 1,271.38
Footnotes
(A) Loss on sale of Fixed Assets
(B) Increase/Decrease in Current Investments
(C) Increase/Decrease in Current Investments
(D) Increase/Decrease in Equity
(E) Increase/Decrease in Equity
(F) Increase/Decrease in Investments
(G) Increase/Decrease in Investments
(H) Increase/Decrease in Borrowings
(I) Increase/Decrease in Borrowings
(J) Buy back of equity premium and its Tax paid - (8228.31) Transitional Reserve - 6.61
79
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
80
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
NOTE 1
1. Background:
Virchow Laboratories Limited (“the company”) was Incorporated in 1982 and its registered office in Hyderabad, Telangana, India. Virchow
Laboratories Limited is the largest producer of Sulfamethoxazole in the world. Virchow also undertakes custom synthesis and manufacture of
drug intermediates and bulk chemicals.
This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.
The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.
81
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
The preparation of financial statements in conformity with Ind AS required management to make judgments, estimates and assumptions that
affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Accounting estimates may
change from period to period. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which
the estimates are revised and if material, their effects are disclosed in the notes to the standalone financial statements.
Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates ('the
functional currency'). These financial statements are prepared in Indian rupee, which is also the functional currency of the Company. All financial
information presented in Indian rupees has been rounded to the nearest Lakhs.
82
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company presents assets and liabilities in the balance sheet based on current/ non-current classification.
• Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period
• There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period
83
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Deferred tax assets and liabilities are classified as non-current assets and liabilities.
The operating cycle is the time between the acquisition of assets for processing and their realization in cash and cash equivalents. The Company
has identified twelve months as its operating cycle.
Transactions in foreign currencies are translated to the functional currencies of the Company at exchange rates at the dates of the transactions.
Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated into the functional currency at the exchange
rate at that date. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at that date when
the fair value was measured. Exchange differences arising on settlements of monetary items or on translating monetary items at rates difference
from those at which they were translated on initial recognition during the period or in the previous financial statements are recognized in the
statement of profit and loss in the period in which they arise with.
f) Revenue Recognition:
· Sale of Goods:
Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.
Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.
· Sales Returns:
84
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.
Interest Income:
Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.
· Dividend Income:
Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.
· Export incentives:
Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.
g) Government Grants:
Grants from the government are recognized at fair value where there is a reasonable assurance that the grant will be received and the company
will comply with the attached conditions.
h) Income tax:
The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.
85
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.
Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.
Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively
The Company presents basic and diluted earnings per share (“EPS”) data for its ordinary shares.
Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of
ordinary shares outstanding during the period.
Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary
shares outstanding for the effects of all dilutive potential ordinary shares.
Items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses, if any.
Cost includes expenditures that are directly attributable to the asset. The cost of self- constructed assets includes the cost of materials and other
costs directly attributable to bringing the asset to a working condition for its intended use. General and Specific borrowing costs that are
attributable to the construction of a qualifying asset are capitalized as part of the cost of the asset during the period of time that is required to
complete and prepare the asset for its intended use or sale.
86
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Gains and losses upon disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the
carrying amount of property, plant and equipment and are recognized in the statement of profit and loss. The costs of repairs and maintenance are
recognized in the statement of profit and loss as incurred.
Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date is disclosed as Capital Advances under
other non-current assets.
Depreciation is recognized in the statement of profit and loss on a Written Down Value (WDV) basis over the estimated useful lives of property,
plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives. Land is not depreciated.
Building 30 to 60 years
Computers 3 years
Furniture 10 years
Vehicles 8 to 10 years
The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period.
Gains or losses on disposal are determined by comparing proceeds with carrying amount.
87
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
l) Intangible assets:
i) Recognition:
In-tangible assets consist of software licenses etc. which are measured at cost on initial recognition and amortized over their estimated useful life.
The Company amortizes intangible assets on a straight line method over a period of six years.
m) Borrowings:
Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.
Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.
n) Borrowing Costs:
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.
o) Leases:
88
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.
As a lessee:
Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.
p) Inventories:
Inventories consists of raw materials, stores and spares, work-in-progress and finished goods and are measured at the lower of cost and net
realizable value. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and the
estimated costs necessary to make the sale.
Cost includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their
existing location and condition. In the case of finished goods and work-in-progress, cost includes an appropriate share of overheads based on
normal operating capacity. Stores and spares, that do not qualify to be recognized as property, plant and equipment, consists of packing materials,
engineering spares (such as machinery spare parts) and consumables which are used for operating machines are consumed as indirect materials in
the manufacturing process.
89
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
i) Classification
The Company classifies its financial assets in the following measurement categories:
- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and
The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.
ii) Measurement
At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.
Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:
Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a
hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.
90
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.
Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.
Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.
Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.
The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.
· the company has transferred the rights to receive cash flow from the financial asset or
· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.
91
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.
Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.
The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to
determine whether there is any indication of impairment.
Financial assets and liabilities are offset and the net amount is reported in the balance sheet where there is a legally enforceable right to offset the
recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The legally
enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default,
insolvency or bankruptcy of the Company or the counterparty.
t) Employee benefits:
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
92
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.
Gratuity obligations
The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.
The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.
The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.
Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.
93
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.
Compensated Absences:
Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.
The Company recognizes a liability and an expense for bonuses. The Company recognizes a provision where contractually obliged or where there
is a past practice that has created a constructive obligation.
For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with
financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to
known amounts of cash and which are subject to an insignificant risk of changes in value. Bank overdrafts are shown within borrowings in current
liabilities in the balance sheet.
v) Trade Receivables:
Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using effective interest method, less provision
for impairment.
94
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These amounts represent liabilities for goods and services provided to the company prior to the end of financial year which are unpaid. The
amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless
payment is not due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at
amortized cost using the effective interest method.
Research and development expenditure, which is of revenue nature, is charged to the profit and loss account, while capital expenditure is added to
the cost of Fixed Assets in the year in which these are incurred.
Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.
Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.
Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.
95
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Ministry of Corporate Affairs (“MCA”) through Companies (Indian Accounting Standards) Amendment Rules, 2019 and Companies (Indian
Accounting Standards) Second Amendment Rules, has notified the following new and amendments to Ind AS which the company has not applied
as they are effective from April 1, 2019:
Ind AS 116 will replace the existing leases standard, Ind AS 17 Leases. Ind AS 116 sets out the principles for the recognition, measurement,
presentation and disclosure of leases for both lessees and lessors. It introduces a single, on-balance sheet lessee accounting model for lessees. A
lessee recognizes right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease
payments. The standard also contains enhanced disclosure requirements for lessees. Ind AS 116 substantially carries forward the lessor
accounting requirements in Ind AS 17.
96
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
97
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
98
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
NOTE 1
1. Background:
Virchow Laboratories Limited (“the company”) was Incorporated in 1982 and its registered office in Hyderabad, Telangana, India. Virchow
Laboratories Limited is the largest producer of Sulfamethoxazole in the world. Virchow also undertakes custom synthesis and manufacture of
drug intermediates and bulk chemicals.
This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.
The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.
99
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
The preparation of financial statements in conformity with Ind AS required management to make judgments, estimates and assumptions that
affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Accounting estimates may
change from period to period. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which
the estimates are revised and if material, their effects are disclosed in the notes to the standalone financial statements.
Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates ('the
functional currency'). These financial statements are prepared in Indian rupee, which is also the functional currency of the Company. All financial
information presented in Indian rupees has been rounded to the nearest Lakhs.
100
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company presents assets and liabilities in the balance sheet based on current/ non-current classification.
• Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period
• There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period
101
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Deferred tax assets and liabilities are classified as non-current assets and liabilities.
The operating cycle is the time between the acquisition of assets for processing and their realization in cash and cash equivalents. The Company
has identified twelve months as its operating cycle.
Transactions in foreign currencies are translated to the functional currencies of the Company at exchange rates at the dates of the transactions.
Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated into the functional currency at the exchange
rate at that date. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at that date when
the fair value was measured. Exchange differences arising on settlements of monetary items or on translating monetary items at rates difference
from those at which they were translated on initial recognition during the period or in the previous financial statements are recognized in the
statement of profit and loss in the period in which they arise with.
f) Revenue Recognition:
· Sale of Goods:
Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.
Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.
· Sales Returns:
102
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.
Interest Income:
Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.
· Dividend Income:
Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.
· Export incentives:
Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.
g) Government Grants:
Grants from the government are recognized at fair value where there is a reasonable assurance that the grant will be received and the company
will comply with the attached conditions.
h) Income tax:
The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.
103
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.
Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.
Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively
The Company presents basic and diluted earnings per share (“EPS”) data for its ordinary shares.
Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of
ordinary shares outstanding during the period.
Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary
shares outstanding for the effects of all dilutive potential ordinary shares.
Items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses, if any.
Cost includes expenditures that are directly attributable to the asset. The cost of self- constructed assets includes the cost of materials and other
costs directly attributable to bringing the asset to a working condition for its intended use. General and Specific borrowing costs that are
attributable to the construction of a qualifying asset are capitalized as part of the cost of the asset during the period of time that is required to
complete and prepare the asset for its intended use or sale.
104
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Gains and losses upon disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the
carrying amount of property, plant and equipment and are recognized in the statement of profit and loss. The costs of repairs and maintenance are
recognized in the statement of profit and loss as incurred.
Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date is disclosed as Capital Advances under
other non-current assets.
Depreciation is recognized in the statement of profit and loss on a Written Down Value (WDV) basis over the estimated useful lives of property,
plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives. Land is not depreciated.
Building 30 to 60 years
Computers 3 years
Furniture 10 years
Vehicles 8 to 10 years
The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period.
Gains or losses on disposal are determined by comparing proceeds with carrying amount.
105
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
l) Intangible assets:
i) Recognition:
In-tangible assets consist of software licenses etc. which are measured at cost on initial recognition and amortized over their estimated useful life.
The Company amortizes intangible assets on a straight line method over a period of six years.
m) Borrowings:
Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.
Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.
n) Borrowing Costs:
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.
o) Leases:
106
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.
As a lessee:
Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.
p) Inventories:
Inventories consists of raw materials, stores and spares, work-in-progress and finished goods and are measured at the lower of cost and net
realizable value. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and the
estimated costs necessary to make the sale.
Cost includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their
existing location and condition. In the case of finished goods and work-in-progress, cost includes an appropriate share of overheads based on
normal operating capacity. Stores and spares, that do not qualify to be recognized as property, plant and equipment, consists of packing materials,
engineering spares (such as machinery spare parts) and consumables which are used for operating machines are consumed as indirect materials in
the manufacturing process.
107
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
i) Classification
The Company classifies its financial assets in the following measurement categories:
- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and
The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.
ii) Measurement
At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.
Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:
Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a
hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.
108
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.
Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.
Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.
Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.
The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.
· the company has transferred the rights to receive cash flow from the financial asset or
· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.
109
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.
Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.
The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to
determine whether there is any indication of impairment.
Financial assets and liabilities are offset and the net amount is reported in the balance sheet where there is a legally enforceable right to offset the
recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The legally
enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default,
insolvency or bankruptcy of the Company or the counterparty.
t) Employee benefits:
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
110
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.
Gratuity obligations
The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.
The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.
The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.
Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.
111
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.
Compensated Absences:
Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.
The Company recognizes a liability and an expense for bonuses. The Company recognizes a provision where contractually obliged or where there
is a past practice that has created a constructive obligation.
For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with
financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to
known amounts of cash and which are subject to an insignificant risk of changes in value. Bank overdrafts are shown within borrowings in current
liabilities in the balance sheet.
v) Trade Receivables:
Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using effective interest method, less provision
for impairment.
112
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These amounts represent liabilities for goods and services provided to the company prior to the end of financial year which are unpaid. The
amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless
payment is not due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at
amortized cost using the effective interest method.
Research and development expenditure, which is of revenue nature, is charged to the profit and loss account, while capital expenditure is added to
the cost of Fixed Assets in the year in which these are incurred.
Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.
Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.
Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.
113
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Ministry of Corporate Affairs (“MCA”) through Companies (Indian Accounting Standards) Amendment Rules, 2019 and Companies (Indian
Accounting Standards) Second Amendment Rules, has notified the following new and amendments to Ind AS which the company has not applied
as they are effective from April 1, 2019:
Ind AS 116 will replace the existing leases standard, Ind AS 17 Leases. Ind AS 116 sets out the principles for the recognition, measurement,
presentation and disclosure of leases for both lessees and lessors. It introduces a single, on-balance sheet lessee accounting model for lessees. A
lessee recognizes right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease
payments. The standard also contains enhanced disclosure requirements for lessees. Ind AS 116 substantially carries forward the lessor
accounting requirements in Ind AS 17.
114
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of additional information about property plant and equipment [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 0 0
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child Refer to child
Refer to child member Refer to child member
equipment member member
Useful lives or depreciation rates, property, Refer to child Refer to child
Refer to child member Refer to child member
plant and equipment member member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
30 30 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
115
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of additional information about property plant and equipment [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 15 15
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 15 15
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(6)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 10 10
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
116
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of additional information about property plant and equipment [Table] ..(7)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 10 10
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(8)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child Refer to child
Refer to child member Refer to child member
equipment member member
Useful lives or depreciation rates, property, Refer to child Refer to child
Refer to child member Refer to child member
plant and equipment member member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(9)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
10 10 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
117
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of additional information about property plant and equipment [Table] ..(10)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
5 5 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(11)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property, plant and equipment
Classes of property, plant and equipment [Axis] Computer equipments [Member]
[Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
3 3 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
Disclosure of additional information about property plant and equipment [Table] ..(12)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 3 3
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount
118
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2018 01/04/2017
31/03/2019 31/03/2018 to to
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 149.13 651.5
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5 10.17
equipment
Total disposals and retirements,
2.5 10.17
property, plant and equipment
Total increase (decrease) in property,
146.63 641.33
plant and equipment
Property, plant and equipment at end of
4,223.02 4,577.9 12,089.99 11,943.36
period
Disclosure of detailed information about property, plant and equipment [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
501.87 480.56
loss
Total Depreciation property plant and
501.87 480.56
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36 7.77
equipment
Total disposals and retirements,
0.36 7.77
property, plant and equipment
Total increase (decrease) in property,
501.51 472.79
plant and equipment
Property, plant and equipment at end of
11,302.03 7,866.97 7,365.46 6,892.67
period
119
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3 0
plant and equipment
Property, plant and equipment at end of
930.04 930.04 926.74 930.04
period
Disclosure of detailed information about property, plant and equipment [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
3.3 0 0
plant and equipment
Property, plant and equipment at end of
930.04 926.74 0 0
period
120
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3
plant and equipment
Property, plant and equipment at end of
0 930.04 930.04 926.74
period
Disclosure of detailed information about property, plant and equipment [Table] ..(6)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3 0
plant and equipment
Property, plant and equipment at end of
930.04 930.04 926.74 0
period
121
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(7)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-105.01 -115.96
loss
Total Depreciation property plant and
-105.01 -115.96
equipment
Total increase (decrease) in property,
0 -105.01 -75.54
plant and equipment
Property, plant and equipment at end of
0 0 1,007.8 1,112.81
period
Disclosure of detailed information about property, plant and equipment [Table] ..(8)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Total increase (decrease) in property,
0 40.42
plant and equipment
Property, plant and equipment at end of
1,188.35 2,375.31 2,375.31 2,334.89
period
122
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(9)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96
loss
Total Depreciation property plant and
105.01 115.96
equipment
Total increase (decrease) in property,
105.01 115.96 0
plant and equipment
Property, plant and equipment at end of
1,367.51 1,262.5 1,146.54 2,375.31
period
Disclosure of detailed information about property, plant and equipment [Table] ..(10)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96
loss
Total Depreciation property plant and
105.01 115.96
equipment
Total increase (decrease) in property,
40.42 105.01 115.96
plant and equipment
Property, plant and equipment at end of
2,375.31 2,334.89 1,367.51 1,262.5
period
123
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(11)
Unless otherwise specified, all monetary values are in Lakhs of INR
Buildings
Classes of property, plant and equipment [Axis] Factory building [Member]
[Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-105.01 -115.96
loss
Total Depreciation property plant and
-105.01 -115.96
equipment
Total increase (decrease) in property,
-105.01 -75.54
plant and equipment
Property, plant and equipment at end of
1,146.54 1,007.8 1,112.81 1,188.35
period
Disclosure of detailed information about property, plant and equipment [Table] ..(12)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01
loss
Total Depreciation property plant and
105.01
equipment
Total increase (decrease) in property,
0 40.42 105.01
plant and equipment
Property, plant and equipment at end of
2,375.31 2,375.31 2,334.89 1,367.51
period
124
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(13)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
115.96 -105.01 -115.96
loss
Total Depreciation property plant and
115.96 -105.01 -115.96
equipment
Total increase (decrease) in property,
115.96 -105.01 -75.54
plant and equipment
Property, plant and equipment at end of
1,262.5 1,146.54 1,007.8 1,112.81
period
Disclosure of detailed information about property, plant and equipment [Table] ..(14)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Total increase (decrease) in property,
0 40.42
plant and equipment
Property, plant and equipment at end of
1,188.35 2,375.31 2,375.31 2,334.89
period
125
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(15)
Unless otherwise specified, all monetary values are in Lakhs of INR
Plant and
Classes of property, plant and equipment [Axis] Factory building [Member] equipment
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 136.51
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96 -277.7
loss
Total Depreciation property plant and
105.01 115.96 -277.7
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.14
equipment
Total disposals and retirements,
2.14
property, plant and equipment
Total increase (decrease) in property,
105.01 115.96 -143.33
plant and equipment
Property, plant and equipment at end of
1,367.51 1,262.5 1,146.54 1,847.94
period
126
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(16)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 227.53 136.51 227.53
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-278.54
loss
Total Depreciation property plant and
-278.54
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
-51.01 134.01 227.53
plant and equipment
Property, plant and equipment at end of
1,991.27 2,042.28 6,928.22 6,794.21
period
127
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(17)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
277.7 278.54
loss
Total Depreciation property plant and
277.7 278.54
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36
equipment
Total disposals and retirements,
0.36
property, plant and equipment
Total increase (decrease) in property,
277.34 278.54
plant and equipment
Property, plant and equipment at end of
6,566.68 5,080.28 4,802.94 4,524.4
period
128
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(18)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 136.51 227.53
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
277.7
loss
Total Depreciation property plant and
277.7
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5 0.36
equipment
Total disposals and retirements,
2.5 0.36
property, plant and equipment
Total increase (decrease) in property,
134.01 227.53 277.34
plant and equipment
Property, plant and equipment at end of
6,928.22 6,794.21 6,566.68 5,080.28
period
129
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(19)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71 171.45
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
278.54 -238.91 -244.26
loss
Total Depreciation property plant and
278.54 -238.91 -244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.14
equipment
Total disposals and retirements,
2.14
property, plant and equipment
Total increase (decrease) in property,
278.54 -113.34 -72.81
plant and equipment
Property, plant and equipment at end of
4,802.94 4,524.4 1,629.37 1,742.71
period
Disclosure of detailed information about property, plant and equipment [Table] ..(20)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71 171.45
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
125.21 171.45
plant and equipment
Property, plant and equipment at end of
1,815.52 6,432.14 6,306.93 6,135.48
period
130
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(21)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
238.91 244.26 -238.91
loss
Total Depreciation property plant and
238.91 244.26 -238.91
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36 2.14
equipment
Total disposals and retirements,
0.36 2.14
property, plant and equipment
Total increase (decrease) in property,
238.55 244.26 -113.34
plant and equipment
Property, plant and equipment at end of
4,802.77 4,564.22 4,319.96 1,629.37
period
131
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(22)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 171.45 127.71 171.45
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-244.26
loss
Total Depreciation property plant and
-244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
-72.81 125.21 171.45
plant and equipment
Property, plant and equipment at end of
1,742.71 1,815.52 6,432.14 6,306.93
period
132
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(23)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
238.91 244.26
loss
Total Depreciation property plant and
238.91 244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36
equipment
Total disposals and retirements,
0.36
property, plant and equipment
Total increase (decrease) in property,
238.55 244.26
plant and equipment
Property, plant and equipment at end of
6,135.48 4,802.77 4,564.22 4,319.96
period
Disclosure of detailed information about property, plant and equipment [Table] ..(24)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-29.47 -29.49
loss
Total Depreciation property plant and
-29.47 -29.49
equipment
Total increase (decrease) in property,
-29.47 1.9 0
plant and equipment
Property, plant and equipment at end of
182.91 212.38 210.48 323.22
period
133
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(25)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.47 29.49
loss
Total Depreciation property plant and
29.47 29.49
equipment
Total increase (decrease) in property,
31.39 29.47 29.49
plant and equipment
Property, plant and equipment at end of
323.22 291.83 140.31 110.84
period
Disclosure of detailed information about property, plant and equipment [Table] ..(26)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-29.47 -29.49
loss
Total Depreciation property plant and
-29.47 -29.49
equipment
Total increase (decrease) in property,
-29.47 1.9
plant and equipment
Property, plant and equipment at end of
81.35 182.91 212.38 210.48
period
134
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(27)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.47
loss
Total Depreciation property plant and
29.47
equipment
Total increase (decrease) in property,
0 31.39 29.47
plant and equipment
Property, plant and equipment at end of
323.22 323.22 291.83 140.31
period
Disclosure of detailed information about property, plant and equipment [Table] ..(28)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8 24.69
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.49 -9.32 -4.79
loss
Total Depreciation property plant and
29.49 -9.32 -4.79
equipment
Total increase (decrease) in property,
29.49 -0.52 19.9
plant and equipment
Property, plant and equipment at end of
110.84 81.35 35.66 36.18
period
135
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(29)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8 24.69
equipment
Total increase (decrease) in property,
8.8 24.69
plant and equipment
Property, plant and equipment at end of
16.28 172.86 164.06 139.37
period
Disclosure of detailed information about property, plant and equipment [Table] ..(30)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
9.32 4.79 -9.32
loss
Total Depreciation property plant and
9.32 4.79 -9.32
equipment
Total increase (decrease) in property,
9.32 4.79 -0.52
plant and equipment
Property, plant and equipment at end of
137.2 127.88 123.09 35.66
period
136
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(31)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 24.69 8.8 24.69
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-4.79
loss
Total Depreciation property plant and
-4.79
equipment
Total increase (decrease) in property,
19.9 8.8 24.69
plant and equipment
Property, plant and equipment at end of
36.18 16.28 172.86 164.06
period
Disclosure of detailed information about property, plant and equipment [Table] ..(32)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
9.32 4.79
loss
Total Depreciation property plant and
9.32 4.79
equipment
Total increase (decrease) in property,
9.32 4.79
plant and equipment
Property, plant and equipment at end of
139.37 137.2 127.88 123.09
period
137
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(33)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-1.31 -1.82
loss
Total Depreciation property plant and
-1.31 -1.82
equipment
Total increase (decrease) in property,
-1.31 -1.82 0
plant and equipment
Property, plant and equipment at end of
5.96 7.27 9.09 79.42
period
Disclosure of detailed information about property, plant and equipment [Table] ..(34)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.31 1.82
loss
Total Depreciation property plant and
1.31 1.82
equipment
Total increase (decrease) in property,
0 1.31 1.82
plant and equipment
Property, plant and equipment at end of
79.42 79.42 73.46 72.15
period
138
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(35)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-1.31 -1.82
loss
Total Depreciation property plant and
-1.31 -1.82
equipment
Total increase (decrease) in property,
-1.31 -1.82
plant and equipment
Property, plant and equipment at end of
70.33 5.96 7.27 9.09
period
Disclosure of detailed information about property, plant and equipment [Table] ..(36)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.31
loss
Total Depreciation property plant and
1.31
equipment
Total increase (decrease) in property,
0 0 1.31
plant and equipment
Property, plant and equipment at end of
79.42 79.42 79.42 73.46
period
139
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(37)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.82 -36.33 -30.6
loss
Total Depreciation property plant and
1.82 -36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.4
equipment
Total disposals and retirements,
2.4
property, plant and equipment
Total increase (decrease) in property,
1.82 -36.33 64.35
plant and equipment
Property, plant and equipment at end of
72.15 70.33 88.33 124.66
period
Disclosure of detailed information about property, plant and equipment [Table] ..(38)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18
plant and equipment
Property, plant and equipment at end of
60.31 357.5 357.5 270.32
period
140
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(39)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6
loss
Total Depreciation property plant and
36.33 30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77
equipment
Total disposals and retirements,
7.77
property, plant and equipment
Total increase (decrease) in property,
36.33 22.83 0
plant and equipment
Property, plant and equipment at end of
269.17 232.84 210.01 357.5
period
141
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(40)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6
loss
Total Depreciation property plant and
36.33 30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17 7.77
equipment
Total disposals and retirements,
10.17 7.77
property, plant and equipment
Total increase (decrease) in property,
87.18 36.33 22.83
plant and equipment
Property, plant and equipment at end of
357.5 270.32 269.17 232.84
period
142
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(41)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member] Motor vehicles [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-36.33 -30.6
loss
Total Depreciation property plant and
-36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.4
equipment
Total disposals and retirements,
2.4
property, plant and equipment
Total increase (decrease) in property,
-36.33 64.35
plant and equipment
Property, plant and equipment at end of
210.01 88.33 124.66 60.31
period
143
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(42)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33
loss
Total Depreciation property plant and
36.33
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18 36.33
plant and equipment
Property, plant and equipment at end of
357.5 357.5 270.32 269.17
period
144
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(43)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
30.6 -36.33 -30.6
loss
Total Depreciation property plant and
30.6 -36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77 2.4
equipment
Total disposals and retirements,
7.77 2.4
property, plant and equipment
Total increase (decrease) in property,
22.83 -36.33 64.35
plant and equipment
Property, plant and equipment at end of
232.84 210.01 88.33 124.66
period
Disclosure of detailed information about property, plant and equipment [Table] ..(44)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18
plant and equipment
Property, plant and equipment at end of
60.31 357.5 357.5 270.32
period
145
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(45)
Unless otherwise specified, all monetary values are in Lakhs of INR
Office equipment
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6 -5.74
loss
Total Depreciation property plant and
36.33 30.6 -5.74
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77
equipment
Total disposals and retirements,
7.77
property, plant and equipment
Total increase (decrease) in property,
36.33 22.83 -3.22
plant and equipment
Property, plant and equipment at end of
269.17 232.84 210.01 13.69
period
Disclosure of detailed information about property, plant and equipment [Table] ..(46)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-10.96
loss
Total Depreciation property plant and
-10.96
equipment
Total increase (decrease) in property,
-10.96 2.52 0
plant and equipment
Property, plant and equipment at end of
16.91 27.87 137.46 134.94
period
146
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(47)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
5.74 10.96
loss
Total Depreciation property plant and
5.74 10.96
equipment
Total increase (decrease) in property,
5.74 10.96
plant and equipment
Property, plant and equipment at end of
134.94 123.77 118.03 107.07
period
Disclosure of detailed information about property, plant and equipment [Table] ..(48)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-5.74 -10.96
loss
Total Depreciation property plant and
-5.74 -10.96
equipment
Total increase (decrease) in property,
-3.22 -10.96 2.52
plant and equipment
Property, plant and equipment at end of
13.69 16.91 27.87 137.46
period
147
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(49)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
5.74 10.96
loss
Total Depreciation property plant and
5.74 10.96
equipment
Total increase (decrease) in property,
0 5.74 10.96
plant and equipment
Property, plant and equipment at end of
134.94 134.94 123.77 118.03
period
Disclosure of detailed information about property, plant and equipment [Table] ..(50)
Unless otherwise specified, all monetary values are in Lakhs of INR
Office equipment
Classes of property, plant and equipment [Axis] Computer equipments [Member]
[Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-6.1 -3.68
loss
Total Depreciation property plant and
-6.1 -3.68
equipment
Total increase (decrease) in property,
2.54 -0.63
plant and equipment
Property, plant and equipment at end of
107.07 14.56 12.02 12.65
period
148
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(51)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
6.1
loss
Total Depreciation property plant and
6.1
equipment
Total increase (decrease) in property,
8.64 3.05 6.1
plant and equipment
Property, plant and equipment at end of
159.43 150.79 147.74 144.87
period
Disclosure of detailed information about property, plant and equipment [Table] ..(52)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
3.68 -6.1 -3.68
loss
Total Depreciation property plant and
3.68 -6.1 -3.68
equipment
Total increase (decrease) in property,
3.68 2.54 -0.63
plant and equipment
Property, plant and equipment at end of
138.77 135.09 14.56 12.02
period
149
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(53)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Total increase (decrease) in property,
8.64 3.05
plant and equipment
Property, plant and equipment at end of
12.65 159.43 150.79 147.74
period
Disclosure of detailed information about property, plant and equipment [Table] ..(54)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property,
plant and
Classes of property, plant and equipment [Axis] Computer equipments [Member]
equipment
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
6.1 3.68 -69.68
loss
Total Depreciation property plant and
6.1 3.68 -69.68
equipment
Total increase (decrease) in property,
6.1 3.68 -68.22
plant and equipment
Property, plant and equipment at end of
144.87 138.77 135.09 314.7
period
150
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(55)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 279.85 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-39
loss
Total Depreciation property plant and
-39
equipment
Total increase (decrease) in property,
240.85 1.46 279.85
plant and equipment
Property, plant and equipment at end of
382.92 142.07 1,122.61 1,121.15
period
Disclosure of detailed information about property, plant and equipment [Table] ..(56)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39
loss
Total Depreciation property plant and
69.68 39
equipment
Total increase (decrease) in property,
69.68 39
plant and equipment
Property, plant and equipment at end of
841.3 807.91 738.23 699.23
period
151
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(57)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68
loss
Total Depreciation property plant and
69.68
equipment
Total increase (decrease) in property,
1.46 279.85 69.68
plant and equipment
Property, plant and equipment at end of
1,122.61 1,121.15 841.3 807.91
period
Disclosure of detailed information about property, plant and equipment [Table] ..(58)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property, plant and equipment Other property, plant and equipment,
Classes of property, plant and equipment [Axis]
[Member] others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Nature of other property plant and equipment Refer to child
Refer to child member
others member
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
39 -69.68 -39
loss
Total Depreciation property plant and
39 -69.68 -39
equipment
Total increase (decrease) in property,
39 -68.22 240.85
plant and equipment
Property, plant and equipment at end of
738.23 699.23 314.7 382.92
period
152
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(59)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Nature of other property plant and equipment
Refer to child member Refer to child member
others
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Total increase (decrease) in property,
1.46 279.85
plant and equipment
Property, plant and equipment at end of
142.07 1,122.61 1,121.15 841.3
period
Disclosure of detailed information about property, plant and equipment [Table] ..(60)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying Carrying amount
Accumulated depreciation and impairment [Member]
amount [Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire
Extinguisher,Weighing
Nature of other property plant and equipment
Refer to child member Refer to child member Machine,R&D
others Equipment,Safety
Equipment and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39 -69.68
loss
Total Depreciation property plant and
69.68 39 -69.68
equipment
Total increase (decrease) in property,
69.68 39 -68.22
plant and equipment
Property, plant and equipment at end of
807.91 738.23 699.23 314.7
period
153
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of detailed information about property, plant and equipment [Table] ..(61)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire Lab Equipment,Fire
Lab Equipment,Fire
Extinguisher,Weighing Extinguisher,Weighing
Nature of other property plant and equipment Extinguisher,Weighing
Machine,R&D Machine,R&D
others Machine,R&D Equipment,Safety
Equipment,Safety Equipment,Safety
Equipment and Boiler
Equipment and Boiler Equipment and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 279.85 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-39
loss
Total Depreciation property plant and
-39
equipment
Total increase (decrease) in property,
240.85 1.46 279.85
plant and equipment
Property, plant and equipment at end of
382.92 142.07 1,122.61 1,121.15
period
Disclosure of detailed information about property, plant and equipment [Table] ..(62)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Gross carrying
Accumulated depreciation and impairment [Member]
amount [Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire Lab Equipment,Fire
Extinguisher,Weighing Extinguisher,Weighing
Nature of other property plant and equipment
Machine,R&D Machine,R&D
others Equipment,Safety Equipment,Safety Equipment
Equipment and Boiler and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39
loss
Total Depreciation property plant and
69.68 39
equipment
Total increase (decrease) in property,
69.68 39
plant and equipment
Property, plant and equipment at end of
841.3 807.91 738.23 699.23
period
154
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.
155
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
156
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Useful lives or depreciation rates, biological assets other than bearer plants, at cost
a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.
157
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Useful lives or depreciation rates, biological assets other than bearer plants, at cost
a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.
158
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
159
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
160
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
161
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
[611600] Notes - Non-current asset held for sale and discontinued operations
Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of non-current assets held for sale and discontinued operations
[TextBlock]
Net cash flows from (used in) operating activities, continuing
6,232.42 7,199.61
operations
Net cash flows from (used in) operating activities, discontinued
0 0
operations
Net cash flows from (used in) operating activities 6,232.42 7,199.61
Net cash flows from (used in) investing activities, continuing
248.11 -676.2
operations
Net cash flows from (used in) investing activities, discontinued
0 0
operations
Net cash flows from (used in) investing activities 248.11 -676.2
Net cash flows from (used in) financing activities, continuing
-5,060.25 -7,768.13
operations
Net cash flows from (used in) financing activities, discontinued
0 0
operations
Net cash flows from (used in) financing activities -5,060.25 -7,768.13
162
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of shareholding more than five per cent in company [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Name of shareholder [Member] Shareholder 1 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Refer to child Sri M. Narayana Sri M. Narayana
Name of shareholder member
Refer to child member
Reddy Reddy
Permanent account number of shareholder AEMPM4585Q AEMPM4585Q
Country of incorporation or residence of
INDIA INDIA
shareholder
Number of shares held in company [shares] 63,784 [shares] 82,899 [shares] 6,017 [shares] 7,917
Percentage of shareholding in company 68.00% 67.00% 6.00% 6.00%
Disclosure of shareholding more than five per cent in company [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 2 [Member] Shareholder 3 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Sri D. Ravindra Sri D. Ravindra Dr L.V. Subba
Name of shareholder Reddy Reddy Reddy
Dr L.V. Subba Reddy
163
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of shareholding more than five per cent in company [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 4 [Member] Shareholder 5 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Dr Nandigala Dr Nandigala Sri Nandigala Sri Nandigala
Name of shareholder Hemanth Hemanth Prasanth Prasanth
Permanent account number of shareholder ACAPN0908Q ACAPN0908Q ABYPN4171A ABYPN4171A
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 7,419 [shares] 9,762 [shares] 7,419 [shares] 9,762
Percentage of shareholding in company 8.00% 8.00% 8.00% 8.00%
Disclosure of shareholding more than five per cent in company [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 6 [Member] Shareholder 7 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Name of shareholder Sri M. Maha Vishnu Sri M. Maha Vishnu Smt. M. Sudha Smt. M. Sudha
Permanent account number of shareholder AAAAA9999A AAAAA9999A AFXPM8911L AFXPM8911L
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 8,322 [shares] 10,950 [shares] 8,322 [shares] 10,950
Percentage of shareholding in company 9.00% 9.00% 9.00% 9.00%
Disclosure of shareholding more than five per cent in company [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 8 [Member] Shareholder 9 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Name of shareholder Sri L.V. Sunil Sri L.V. Sunil Sri L.V. Subash Sri L.V. Subash
Permanent account number of shareholder BBBBB9999B BBBBB9999B ABNPL3249E ABNPL3249E
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 6,734 [shares] 8,860 [shares] 6,250 [shares] 8,224
Percentage of shareholding in company 7.00% 7.00% 7.00% 7.00%
164
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
165
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
166
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.
Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.
167
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of temporary difference, unused tax losses and unused tax credits [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Depreciation
amortisation
Temporary difference, unused tax losses and unused tax credits [Axis] Temporary differences [Member]
impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of temporary difference, unused tax
losses and unused tax credits [Abstract]
Disclosure of temporary difference, unused
tax losses and unused tax credits [Line items]
Deferred tax assets and liabilities [Abstract]
Deferred tax liabilities 86.01 173.53 86.01
Net deferred tax liability (assets) 86.01 173.53 173.53 86.01
Deferred tax expense (income) [Abstract]
Deferred tax expense (income)
Deferred tax expense (income)
-87.52 0 -87.52
recognised in profit or loss
Reconciliation of changes in deferred tax
liability (assets) [Abstract]
Changes in deferred tax liability (assets)
[Abstract]
Deferred tax expense (income)
-87.52 0 -87.52
recognised in profit or loss
Total increase (decrease) in deferred
-87.52 0 -87.52
tax liability (assets)
Deferred tax liability (assets) at end of
86.01 173.53 173.53 86.01
period
Disclosure of temporary difference, unused tax losses and unused tax credits [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Depreciation amortisation impairment
Temporary difference, unused tax losses and unused tax credits [Axis]
[Member]
01/04/2017
to 31/03/2017
31/03/2018
Disclosure of temporary difference, unused tax losses and unused tax credits [Abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [Line
items]
Deferred tax assets and liabilities [Abstract]
Deferred tax liabilities 173.53
Net deferred tax liability (assets) 173.53 173.53
Deferred tax expense (income) [Abstract]
Deferred tax expense (income)
Deferred tax expense (income) recognised in profit or loss 0
Reconciliation of changes in deferred tax liability (assets) [Abstract]
Changes in deferred tax liability (assets) [Abstract]
Deferred tax expense (income) recognised in profit or loss 0
Total increase (decrease) in deferred tax liability (assets) 0
Deferred tax liability (assets) at end of period 173.53 173.53
168
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
169
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.
Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.
Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.
Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively
[611900] Notes - Accounting for government grants and disclosure of government assistance
Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of accounting for government grants and disclosure of government
assistance [TextBlock]
Whether company has received any government grant or government assistance No No
170
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
171
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
172
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
173
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
174
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
175
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
176
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
177
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
· Sale of Goods:
Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.
Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.
· Sales Returns:
The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.
Interest Income:
Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.
· Dividend Income:
Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.
· Export incentives:
Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.
178
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
179
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
180
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
181
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.
Gratuity obligations
The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.
The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.
182
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.
Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.
The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.
Compensated Absences:
Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.
183
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.
Gratuity obligations
The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.
The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.
184
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.
Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.
The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.
Compensated Absences:
Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.
185
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
[700100] Notes - Key managerial personnels and directors remuneration and other information
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 1 2 3 4
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
RAVINDRA
VENKATA REDDY NARAYANA REDDY VENGA
Name of key managerial personnel or director SUDHA MUNDLA
ALLA REDDY MUNDLA R E D D Y
KUTAGULLA
Director identification number of key managerial
00054013 07701625 00064392 00083986
personnel or director
Permanent account number of key managerial
AFXPM8911L AMFPA4063J AEMPM4585Q AKLPK4260D
personnel or director
Date of birth of key managerial personnel or
19/04/1982 05/01/1940 01/06/1951 19/04/1942
director
Designation of key managerial personnel or director Director Director Managing Director Director
Qualification of key managerial personnel or
B. Tech & MBA Graduate M.SC Graduate
director
Shares held by key managerial personnel or director [shares] 8,322 [shares] 0 [shares] 6,017 [shares] 0
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 0 0 12 0
Perquisites key managerial personnel or
0 0 0 0
director
Profits in lieu of salary key managerial
0 0 2.45 0
personnel or director
Gross salary to key managerial personnel or
0 0 14.45 0
director
Sitting fees key managerial personnel or
0 0 0 0
director
Stock option key managerial personnel or
0 0 0 0
director
Sweat equity key managerial personnel or
0 0 0 0
director
Commission as percentage of profit key
0 0 0 0
managerial personnel or director
Other commission key managerial personnel or
0 0 0 0
director
Other compensation key managerial personnel or
0 0 0 0
director
Total key managerial personnel or director
0 0 14.45 0
remuneration
186
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 5 6 7 8
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
VENKATA LINGAREDDY
HEMANTH NANDIGALA
Name of key managerial personnel or director SUBASH SUBBA REDDY
NANDIGALA VENKATA REDDY
LINGAREDDY VENKATA
Director identification number of key managerial
00125240 00135847 01561731 01740424
personnel or director
Permanent account number of key managerial
ABNPL3249E AAVPL5579L ACAPN0908Q ABNPN2622B
personnel or director
Date of birth of key managerial personnel or
09/12/1971 01/07/1941 02/01/1974 01/07/1943
director
Designation of key managerial personnel or director Director Director Director Managing Director
Qualification of key managerial personnel or
B. Tech & MBA Graduate MBBS & MBA MBBS
director
Shares held by key managerial personnel or director [shares] 6,250 [shares] 6,922 [shares] 7,419 [shares] 3,779
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 0 0 0 12
Perquisites key managerial personnel or
0 0 0 0
director
Profits in lieu of salary key managerial
0 0 0 2.57
personnel or director
Gross salary to key managerial personnel or
0 0 0 14.57
director
Sitting fees key managerial personnel or
0 0 0 0
director
Stock option key managerial personnel or
0 0 0 0
director
Sweat equity key managerial personnel or
0 0 0 0
director
Commission as percentage of profit key
0 0 0 0
managerial personnel or director
Other commission key managerial personnel or
0 0 0 0
director
Other compensation key managerial personnel or
0 0 0 0
director
Total key managerial personnel or director
0 0 0 14.57
remuneration
187
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 9 10
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [Abstract]
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [LineItems]
PRASANTH
Name of key managerial personnel or director NANDIGALA
GARGI PAMMI
Shares held by key managerial personnel or director [shares] 7,419 [shares] 2,256
Key managerial personnel or director remuneration [Abstract]
Gross salary to key managerial personnel or director [Abstract]
Salary key managerial personnel or director 0 0
Perquisites key managerial personnel or director 0 0
Profits in lieu of salary key managerial personnel or director 0 0
Gross salary to key managerial personnel or director 0 0
Sitting fees key managerial personnel or director 0 0
Stock option key managerial personnel or director 0 0
Sweat equity key managerial personnel or director 0 0
Commission as percentage of profit key managerial personnel or director 0 0
Other commission key managerial personnel or director 0 0
Other compensation key managerial personnel or director 0 0
Total key managerial personnel or director remuneration 0 0
188
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.
As a lessee:
Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.
189
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
190
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Cost taxes other levies by government local authorities (K) 0.11 (L) 0.11
Provision wealth tax 0
(M) 0.02
Total rates and taxes excluding taxes on income 24.25 192.26
Research development expenditure 116.89 115.21
Electricity expenses 97.22 73.03
Telephone postage 38.02 32.53
Printing stationery 49.21 39.53
Travelling conveyance 58.18 64.45
Legal professional charges 28.39 36.85
Vehicle running expenses 8.91 13.63
Directors sitting fees 0 0
Donations subscriptions 11.82 1.82
Registration filing fees 57.8 59.17
Advertising promotional expenses 330.82 293.61
191
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Footnotes
(A) Income from investments mandatorily measured at fair value through profit or loss
(B) Income from investments mandatorily measured at fair value through profit or loss
(C) Profit on redemption of investments
(D) Profit on redemption of investments
(E) Interest on others
(F) Interest on others
(G) Bank Charges
(H) Bank Charges
(I) Contribution to ESI - 18.77 Bonus - 48.02
(J) Contribution to ESI - 20.68 Bonus - 50.16
(K) Professional Tax
(L) Professional Tax
(M) Interest on TDS
(N) Clearing and Forward Charges - 567.64 Consignment Expenses - 1.24
(O) Clearing and Forward Charges - 528.49 Consignment Expenses - 6.46
(P) Sales Commission
(Q) Sales Commission
(R) Lab Maintenance
(S) Lab Maintenance
(T) Miscellaneous Expenses - 10.71 Office Expenses - 7.09 EMS Expenses - 1.28
(U) Miscellaneous Expenses - 22.73 Office Expenses - 7.27 EMS Expenses - 4.16
192
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
193
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
i) Classification
The Company classifies its financial assets in the following measurement categories:
- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and
The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.
ii) Measurement
At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.
Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:
Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a
194
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.
Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.
Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.
Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.
Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.
The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.
195
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
· the company has transferred the rights to receive cash flow from the financial asset or
· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.
Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.
Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.
196
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
197
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
198
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
199
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
200
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
201
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
202
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
transaction
Expense recognised during period
for bad
0 0 0 0
and doubtful debts for related party
transaction
203
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
204
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
205
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
206
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
Disclosure of other provisions, contingent liabilities and contingent assets [Text Block]
a) Provisions, contingent liabilities and contingent assets:
Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.
Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.
Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.
Disclosure of net profits for last three financial years [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Financial year 1 Financial year 2 Financial year 3
Net profits for last three financial years [Axis]
[Member] [Member] [Member]
01/04/2018 01/04/2018 01/04/2018
to to to
31/03/2019 31/03/2019 31/03/2019
Disclosure of net profits for last three financial years [Abstract]
Disclosure of net profits for last three financial years [LineItems]
Description of financial year 2017-18 2016-17 2015-16
Profit before tax of financial year 3,449.01 7,514.41 6,910.85
Net profit computed u/s 198 and adjusted as per rule 2(1)(f)
3,449.01 7,514.41 6,910.85
of Companies (CSR Policy) Rules, 2014
207
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
208
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
209
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
The CSR committee of the Board has developed CSR Policy consist of
a) Eradicating poverty, promoting health care & sanitation and making available safe drinking water
b) Promoting education
d) Sports promotion
210
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
211
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:
· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;
· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.
212